Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-19-000132
Filing Date
2019-02-25
Accepted
2019-02-25 17:32:42
Documents
1
Period of Report
2019-02-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT prnb.html 3  
1 OWNERSHIP DOCUMENT prnb.xml 3 4589
  Complete submission text file 0000903423-19-000132.txt   6255
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 3 | Act: 34 | File No.: 001-36289 | Film No.: 19630706
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)